These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 36625419

  • 1. Clinical associations of patients with anti-3-hydroxy-3-methylglutaryl CoA reductase antibody-associated immune-mediated necrotising myopathy.
    Tan E, Knight J, Khonasti S, Nolan D, McGettigan B, Bundell C, Needham M, Brusch A.
    Intern Med J; 2023 Oct; 53(10):1846-1853. PubMed ID: 36625419
    [Abstract] [Full Text] [Related]

  • 2. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y, Uruha A, Suzuki S, Nakahara J, Hamanaka K, Takayama K, Suzuki N, Nishino I.
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
    [Abstract] [Full Text] [Related]

  • 3. Challenges in the diagnosis and management of immune-mediated necrotising myopathy (IMNM) in a patient on long-term statins.
    Khan F, Brady S, Kuttikat A.
    Rheumatol Int; 2023 Feb; 43(2):383-390. PubMed ID: 36260115
    [Abstract] [Full Text] [Related]

  • 4. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure.
    Shovman O, Gilburd B, Chayat C, Lazar AD, Amital H, Blank M, Bentow C, Mahler M, Shoenfeld Y.
    Immunol Res; 2017 Feb; 65(1):276-281. PubMed ID: 27618830
    [Abstract] [Full Text] [Related]

  • 5. Anti-HMGCR immune-mediated necrotising myopathy: Addressing the remaining issues.
    Khoo T, Chinoy H.
    Autoimmun Rev; 2023 Dec; 22(12):103468. PubMed ID: 37884200
    [Abstract] [Full Text] [Related]

  • 6. Treatment and outcomes in anti-HMG-CoA reductase-associated immune-mediated necrotising myopathy. Comparative analysis of a single-centre cohort and published data.
    Rademacher JG, Glaubitz S, Zechel S, Oettler M, Tampe B, Schmidt J, Korsten P.
    Clin Exp Rheumatol; 2022 Feb; 40(2):320-328. PubMed ID: 35225222
    [Abstract] [Full Text] [Related]

  • 7. Cutaneous involvement in anti-HMGCR positive necrotizing myopathy.
    Williams B, Horn MP, Banz Y, Feldmeyer L, Villiger PM.
    J Autoimmun; 2021 Sep; 123():102691. PubMed ID: 34332436
    [Abstract] [Full Text] [Related]

  • 8. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
    Jiao Y, Cai S, Lin J, Zhu W, Xi J, Li J, Yue D, Zhang T, Qiao K, Wang Y, Zhao C, Lu J.
    J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
    [Abstract] [Full Text] [Related]

  • 9. [Two cases of statin-induced immune-mediated necrotizing myopathy].
    Safi T, Wagner H.
    Lakartidningen; 2021 Dec 01; 118():. PubMed ID: 34861042
    [Abstract] [Full Text] [Related]

  • 10. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.
    Werner JL, Christopher-Stine L, Ghazarian SR, Pak KS, Kus JE, Daya NR, Lloyd TE, Mammen AL.
    Arthritis Rheum; 2012 Dec 01; 64(12):4087-93. PubMed ID: 22933019
    [Abstract] [Full Text] [Related]

  • 11. Clinico-serologic features of statin-induced necrotising autoimmune myopathy in a single-centre cohort.
    Waters MJ, Limaye V.
    Clin Rheumatol; 2018 Feb 01; 37(2):543-547. PubMed ID: 28905130
    [Abstract] [Full Text] [Related]

  • 12. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
    Lahaye C, Beaufrére AM, Boyer O, Drouot L, Soubrier M, Tournadre A.
    Joint Bone Spine; 2014 Jan 01; 81(1):79-82. PubMed ID: 23953224
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mushroom supplements triggering a flare of HMGCR immune mediated necrotising myopathy.
    Adler B, Christopher-Stine L, Tiniakou E.
    BMJ Case Rep; 2022 May 23; 15(5):. PubMed ID: 35606030
    [Abstract] [Full Text] [Related]

  • 15. [Anti-HMGCR immune-mediated necrotizing myopathy: A case report].
    Zhang YJ, Ma JY, Liu XY, Zheng DF, Zhang YS, Li XG, Fan DS.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun 18; 55(3):558-562. PubMed ID: 37291935
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience.
    Klein M, Mann H, Pleštilová L, Zámečník J, Betteridge Z, McHugh N, Vencovský J.
    Rheumatology (Oxford); 2015 Nov 18; 54(11):2010-4. PubMed ID: 26109604
    [Abstract] [Full Text] [Related]

  • 18. Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level.
    Aggarwal R, Moghadam-Kia S, Lacomis D, Malik A, Qi Z, Koontz D, Burlingame RW, Oddis CV.
    Scand J Rheumatol; 2020 Sep 18; 49(5):405-411. PubMed ID: 31801390
    [Abstract] [Full Text] [Related]

  • 19. Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies: incidence using different testing criteria, and case series.
    Joseph VMK, Rose EC, Edwards CJ, Lloyd M, Amar SK, Wheeler RD, Forster T, Smith KA, Eren E, Hughes R, Hajela V, Kiely PDW.
    Clin Exp Rheumatol; 2022 Feb 18; 40(2):298-303. PubMed ID: 35200125
    [Abstract] [Full Text] [Related]

  • 20. Statin-induced anti-HMGCR antibody-related immune-mediated necrotising myositis achieving complete remission with rituximab.
    Zhang W, Prince HM, Reardon K.
    BMJ Case Rep; 2019 Dec 01; 12(11):. PubMed ID: 31791994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.